The role partners closely with U.S. Medical, Health Outcomes, Epidemiology, Implementation Science, R&D, Market Access, ViiV Corporate Accounts Team (VCAT), ViiV Corporate Accounts Reimbursement Team (VCART), and other field medical leaders to provide a seamless and compliant customer experience. This leader sets direction for medical account strategy and execution across the portfolio and pipeline, ensuring National MVOLs deliver timely, evidence-based clinical, economic and humanistic value engagements that support informed access, management and purchase-based decisions.